U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06907420) titled '40 Hz Visual Stimulation As an Intervention in Schizophrenia' on March 14.
Brief Summary: In schizophrenia, an abnormal reduction in neuronal gamma oscillations (30-100 Hz) is associated with negative symptoms such as cognitive dysfunction. The literature suggests that rescuing gamma oscillations through non-invasive brain stimulation may be an accessible and safe add-on strategy to mitigate negative symptoms. Here, a stimulation protocol based on gamma visual stimulation will be tested. This pilot study will follow an uncontrolled clinical trial design: A minimum of ten patients diagnosed with schizophrenia or a schizoaffective dis...